1 |
Saulnier, D.M., Riehle, K., Mistretta, T.A., Diaz, M.A., Mandal, D., Raza, S., Weidler, E.M., Qin, X., Coarfa, C., Milosavljevic, A., and et al. 2011. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141, 1782 -1791.
DOI
ScienceOn
|
2 |
Singh, R., Nieuwdorp, M., Berge, I., Bemelman, F., and Geerlings, S. 2014. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Clin. Microbiol. Infect. doi: 10.1111/1469-0691.12799.
DOI
|
3 |
Smith, M.B., Kelly, C., and Alm, E.J. 2014. Policy: How to regulate faecal transplants. Nature 506, 290-291.
DOI
|
4 |
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., and et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105, 16731-16736.
DOI
ScienceOn
|
5 |
Sprinz, H., Kundel, D.W., Dammin, G.J., Horowitz, R.E., Schneider, H., and Formal, S.B. 1961. The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri. Am. J. Pathol. 39, 681-695.
|
6 |
Stappenbeck, T.S., Hooper, L.V., and Gordon, J.I. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 99, 15451-15455.
DOI
ScienceOn
|
7 |
Sullivan, A., Edlund, C., and Nord, C.E. 2001. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1, 101-114.
DOI
ScienceOn
|
8 |
Surawicz, C.M. and Alexander, J. 2011. Treatment of refractory and recurrent Clostridium difficile infection. Nat. Rev. Gastroenterol. Hepatol. 8, 330-339.
DOI
|
9 |
Taymount. 2010. Probiotics can help behaviour, ADD and Asthma. Taymount FMT Clinic Wednesday, 18 August 1.
|
10 |
Thomas, F., Hehemann, J.H., Rebuffet, E., Czjzek, M., and Michel, G. 2011. Environmental and gut bacteroidetes: the food connection. Front. Microbiol. 30, 93.
|
11 |
Turnbaugh, P.J., Backhed, F., Fulton, L., and Gordon, J.I. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223.
DOI
ScienceOn
|
12 |
van Nood, E., Speelman, P., Kuijper, E.J., and Keller, J.J. 2009. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill. 14, pii=19316.
|
13 |
van Nood, E., Speelman, P., Nieuwdorp, M., and Keller, J. 2014. Fecal microbiota transplantation: facts and controversies. Curr. Opin. Gastroenterol. 30, 34-39.
DOI
|
14 |
Vrieze, A., de Groot, P.F., Kootte, R.S., Knaapen, M., van Nood, E., and Nieuwdorp, M. 2013. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Pract. Res. Clin. Gastroenterol. 27, 127-137.
DOI
|
15 |
Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., and et al. 2012. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916.
DOI
ScienceOn
|
16 |
Walsh, N. 2014. Frozen or Powdered: Fecal Transplant Works in C. Diff. Med Page Today.
|
17 |
Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Bjorksten, B., Engstrand, L., and Jenmalm, M.C. 2012. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 129, 434-440.
DOI
|
18 |
Wong, J.M., de Souza, R., Kendall, C.W., Emam, A., and Jenkins, D.J. 2006. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235-243.
DOI
ScienceOn
|
19 |
You, D.M., Franzos, M.A., and Holman, R.P. 2008. Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann. Intern. Med. 148, 632-633.
DOI
ScienceOn
|
20 |
Zoetendal, E.G., Vaughan, E.E., and de Vos, W.M. 2006. A microbial world within us. Mol. Microbiol. 59, 1639-1650.
DOI
ScienceOn
|
21 |
Aroniadis, O.C. and Brandt, L.J. 2013. Fecal microbiota transplantation: past, present and future. Curr. Opin. Gastroenterol. 29, 79-84.
DOI
|
22 |
Bakken, J.S., Borody, T., Brandt, L.J., Brill, J.V., Demarco, D.C., Franzos, M.A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L.P., and et al. 2011. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 9, 1044-1049.
DOI
ScienceOn
|
23 |
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., and et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341.
DOI
ScienceOn
|
24 |
Bajaj, J.S., Ridlon, J.M., Hylemon, P.B., Thacker, L.R., Heuman, D.M., Smith, S., Sikaroodi, M., and Gillevet, P.M. 2012. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol. Gastrointest Liver Physiol. 302, G168-175.
DOI
|
25 |
Bakken, J.S. 2009. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15, 285-289.
DOI
ScienceOn
|
26 |
Belluck, P. 2014. A promising pill, not so hard to swallow. The new York Times, Vol. October 12, p. A21.
|
27 |
Berggren, A.M., Nyman, E.M., Lundquist, I., and Bjorck, I.M. 1996. Influence of orally and rectally administered propionate on cholesterol and glucose metabolism in obese rats. Br. J. Nutr. 76, 287-294.
DOI
ScienceOn
|
28 |
Borody, T., Nowak, A., Torres, M., Campbell, J., Finlayson, S., and Leis, S. 2012. Bacteriotherapy in Chronic Fatigue Syndrome (CFS): a retrospective review. Am. J. Gastroenterol. 107, S591-S592.
|
29 |
Borody, T.J. and Khoruts, A. 2011. Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9, 88-96.
DOI
ScienceOn
|
30 |
Brandt, L.J., Aroniadis, O.C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., and Surawicz, C. 2012. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107, 1079-1087.
DOI
ScienceOn
|
31 |
Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M., and Young, V.B. 2008. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197, 435-438.
DOI
ScienceOn
|
32 |
Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., and Relman, D.A. 2005. Diversity of the human intestinal microbial flora. Science 308, 1635- 1638.
DOI
ScienceOn
|
33 |
Eiseman, B., Silen, W., Bascom, G.S., and Kauvar, A.J. 1958. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44, 854-859.
|
34 |
Falk, P.G., Hooper, L.V., Midtvedt, T., and Gordon, J.I. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62, 1157-1170.
|
35 |
Feltman, R. 2014. Good news: You can take your fecal transplants orally. The Washington Post.
|
36 |
Frankel, W.L., Zhang, W., Singh, A., Klurfeld, D.M., Don, S., Sakata, T., Modlin, I., and Rombeau, J.L. 1994. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 106, 375-380.
DOI
|
37 |
Freeman, H.J. 2013. Long-term follow-up of patients with malignant pedunculated colon polyps after colonoscopic polypectomy. Can. J. Gastroenterol. 27, 20-24.
DOI
|
38 |
Giongo, A., Gano, K.A., Crabb, D.B., Mukherjee, N., Novelo, L.L., Casella, G., Drew, J.C., Ilonen, J., Knip, M., Hyoty, H., and et al. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5, 82-91.
DOI
|
39 |
George, J.N. 2010. Management of immune thrombocytopenia--something old, something new. The New Engl. J. Med. 363, 1959-1961.
DOI
|
40 |
Gibson, G.R. 2004. Fibre and effects on probiotics (the prebiotic concept). Clinical Nutrition Supplements 1, 25-31.
|
41 |
Gough, E., Shaikh, H., and Manges, A.R. 2011. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994- 1002.
DOI
ScienceOn
|
42 |
Guarner, F. and Malagelada, J.R. 2003. Gut flora in health and disease. Lancet 361, 512-519.
DOI
ScienceOn
|
43 |
Guo, B., Harstall, C., Louie, T., Veldhuyzen van Zanten, S., and Dieleman, L.A. 2012. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment. Pharmacol. Ther. 35, 865-875.
DOI
ScienceOn
|
44 |
Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., and Brummer, R.J. 2008. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104-119.
|
45 |
Hapfelmeier, S., Lawson, M.A., Slack, E., Kirundi, J.K., Stoel, M., Heikenwalder, M., Cahenzli, J., Velykoredko, Y., Balmer, M.L., Endt, K., and et al. 2010. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 328, 1705-1709.
DOI
|
46 |
Ismail, N.A., Ragab, S.H., ElBaky, A.A., Shoeib, A.R., Alhosary, Y., and Fekry, D. 2010. Frequency of Firmicutes and Bacteroidetes in gut microbiota of obese and normal weight Egyptian children and adults. Arch. Med. Sci. 7, 501-507.
|
47 |
Haverson, K., Rehakova, Z., Sinkora, J., Sver, L., and Bailey, M. 2007. Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: a study in germ-free pigs. Vet. Immunol. Immunopathol. 119, 243-253.
DOI
|
48 |
Hill, D.A. and Artis, D. 2010. Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28, 623-667.
DOI
ScienceOn
|
49 |
Hooper, L.V. and Gordon, J.I. 2001. Commensal host-bacterial relationships in the gut. Science 292, 1115-1118.
DOI
ScienceOn
|
50 |
Ivanov, II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., and et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498.
DOI
ScienceOn
|
51 |
Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson, C.A., and et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.
DOI
ScienceOn
|
52 |
Kaplan, K. 2014. Study: Frozen poop pills may make fecal transplants simpler and safer los angeles times, Vol. Oct 11.
|
53 |
Kelly, C.P. and LaMont, J.T. 2008. Clostridium difficile--more difficult than ever. New Engl. J. Med. 359, 1932-1940.
DOI
ScienceOn
|
54 |
Lawley, T.D., Clare, S., Walker, A.W., Stares, M.D., Connor, T.R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., and Brandt, C. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995.
DOI
|
55 |
Kelly, D., Delday, M.I., and Mulder, I. 2012. Microbes and microbial effector molecules in treatment of inflammatory disorders. Immunol. Rev. 245, 27-44.
DOI
|
56 |
Kriegel, M.A., Sefik, E., Hill, J.A., Wu, H.J., Benoist, C., and Mathis, D. 2011. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 108, 11548-11553.
DOI
|
57 |
Kunde, S., Pham, A., Bonczyk, S., Crumb, T., Duba, M., Conrad, H. Jr., Cloney, D., and Kugathasan, S. 2013. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 56, 597-601.
DOI
|
58 |
Lay, C., Rigottier-Gois, L., Holmstrom, K., Rajilic, M., Vaughan, E.E., de Vos, W.M., Collins, M.D., Thiel, R., Namsolleck, P., and Blaut, M. 2005. Colonic microbiota signatures across five northern European countries. Appl. Environ. Microbiol. 71, 4153-4155.
DOI
ScienceOn
|
59 |
Ley, R.E., Peterson, D.A., and Gordon, J.I. 2006a. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848.
DOI
ScienceOn
|
60 |
Ley, R.E., Turnbaugh, P.J., Klein, S., and Gordon, J.I. 2006b. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
DOI
ScienceOn
|
61 |
Marchesi, J.R. 2010. Prokaryotic and eukaryotic diversity of the human gut. Adv. Appl. Microbiol. 72, 43-62.
DOI
|
62 |
Lo Vecchio, A. and Cohen, M.B. 2014. Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers. Curr. Opin. Gastroenterol. 30, 47-53.
DOI
|
63 |
Luckey, D., Marietta, E., Luthra, H.S., Patel, R., Murray, J.A., Mangalam, A. and Taneja, V. 2012. Commensal gut-derived bacteria as therapy for systemic autoimmune disease. Arthritis Rheumatism 64, Suppl 10:1636.
|
64 |
Macpherson, A.J. and Harris, N.L. 2004. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478-485.
DOI
ScienceOn
|
65 |
Mariat, D., Firmesse, O., Levenez, F., Guimaraes, V., Sokol, H., Dore, J., Corthier, G., and Furet, J. 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 123.
DOI
ScienceOn
|
66 |
Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., and Kasper, D.L. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118.
DOI
ScienceOn
|
67 |
McIntosh, J. 2014. FDA struggles to regulate fecal transplants. CBS News/AP/ June 26, 2014, 5:35 PM.
|
68 |
Megerlin, F., Fouassier, E., Lopert, R., and Bourlioux, P. 2014. Faecal microbiota transplantation: A sui generis biological drug, not a tissue. Ann. Pharm. Fr. 72, 217-220.
DOI
|
69 |
Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B.C., Monack, D.M., and et al. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99.
DOI
|
70 |
Nistal, E., Caminero, A., Herran, A.R., Arias, L., Vivas, S., de Morales, J.M., Calleja, S., de Miera, L.E., Arroyo, P., and Casqueiro, J. 2012. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm. Bowel Dis. 18, 649-656.
DOI
|
71 |
Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., and Brown, P.O. 2007. Development of the human infant intestinal microbiota. PLoS Biol. 5, e177.
DOI
|
72 |
Prakash, S., Rodes, L., Coussa-Charley, M., and Tomaro-Duchesneau, C. 2011. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5, 71-86.
|
73 |
Rajilic-Stojanovic, M., Biagi, E., Heilig, H.G., Kajander, K., Kekkonen, R.A., Tims, S., and de Vos, W.M. 2011. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801.
DOI
ScienceOn
|
74 |
Reardon, S. 2014. Microbiome therapy gains market traction. Nature 509, 269-270.
DOI
|
75 |
Research, C.f.B.E.a. 2013. Guidance for industry: Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. Food and Drug Administration, 1-4.
|
76 |
Roberfroid, M.B., Bornet, F., Bouley, C., and Cummings, J.H. 1995. Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr. Rev. 53, 127-130.
|
77 |
Round, J.L. and Mazmanian, S.K. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323.
DOI
ScienceOn
|